Evidence map›Paper›PMID 31993169›Full record

ArticleFood science & nutrition2020

Antihyperglycemic effect of rice husk derived xylooligosaccharides in high-fat diet and low-dose streptozotocin-induced type 2 diabetic rat model.

Nuntawat Khat-Udomkiri, Parichart Toejing, Sasithorn Sirilun, Chaiyavat Chaiyasut, Narissara Lailerd

Open access · hybridAbstract read
In one paragraph

Article in Food science & nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Influence ofFoods (Basel, Switzerland) · 2021
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nuntawat Khat-UdomkiriInnovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals Faculty of Pharmacy Chiang Mai University Chiang Mai Thailand.
Parichart ToejingDepartment of Physiology Faculty of Medicine Chiang Mai University Chiang Mai Thailand.
Sasithorn SirilunInnovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals Faculty of Pharmacy Chiang Mai University Chiang Mai Thailand.
Chaiyavat ChaiyasutInnovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals Faculty of Pharmacy Chiang Mai University Chiang Mai Thailand.ORCID https://orcid.org/0000-0002-1633-2419
Narissara LailerdInnovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals Faculty of Pharmacy Chiang Mai University Chiang Mai Thailand.ORCID https://orcid.org/0000-0002-5439-5365
Chiang Mai University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rice husk (RH) is an agricultural waste obtained from rice milling process. Our previous study demonstrated the optimized process of extracting xylooligosaccharides (XOS), a prebiotic that can support the growth and activity of beneficial gut microbiota, from RH. Accumulated evidences indicate that the composition of gut microbiota is involved in the progression of insulin resistance and diabetes. This study aims to evaluate the antihyperglycemic effect and putative mechanisms of RH-XOS using a diabetic rat model induced by high-fat diet and streptozotocin injection. Diabetic rats were randomly assigned to receive vehicle (DMC), XOS (DM-XOS), metformin (DMM), and a combination of XOS and metformin (DMM-XOS). An additional group of rats were fed with normal diet plus vehicle (NDC) and normal diet plus XOS (ND-XOS). Supplementation with RH-XOS for 12 weeks successfully decreased the fasting plasma glucose, insulin, leptin, and LPS levels in DM-XOS compared with DMC. Likewise, the insulin-stimulated glucose uptake assessed by in vitro study was significantly enhanced in DM-XOS, DMM, and DMM-XOS. The diminished protein expressions of GLUT4 and pAkt

Indexed as

antihyperglycemiadiabetes mellitusgut microbiotaprebioticrice huskxylooligosaccharides

Identifiers

PMID31993169
PMCPMC6977422
OpenAlexW2994648799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.